Some incredible advancements in cancer research and care are being announced this week in Chicago. The American Association ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...